Exencial Wealth Advisors LLC Has $201,000 Position in HCA Healthcare, Inc. (NYSE:HCA)

Exencial Wealth Advisors LLC lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 6.3% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 670 shares of the company’s stock after selling 45 shares during the period. Exencial Wealth Advisors LLC’s holdings in HCA Healthcare were worth $201,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of HCA. MML Investors Services LLC raised its position in HCA Healthcare by 31.7% during the third quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock worth $7,241,000 after acquiring an additional 4,285 shares in the last quarter. Meritage Group LP acquired a new stake in HCA Healthcare in the 3rd quarter valued at about $150,548,000. Galvin Gaustad & Stein LLC acquired a new position in HCA Healthcare during the fourth quarter worth approximately $18,044,000. Alpha DNA Investment Management LLC acquired a new stake in shares of HCA Healthcare in the third quarter valued at approximately $869,000. Finally, NRI Wealth Management LC bought a new stake in HCA Healthcare in the 4th quarter valued at $2,896,000. 62.73% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Royal Bank of Canada decreased their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a report on Monday, January 27th. Bank of America cut their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research report on Monday, January 27th. Raymond James lowered HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. Cantor Fitzgerald reiterated an “overweight” rating and set a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. Finally, JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average target price of $385.67.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the business’s stock in a transaction that occurred on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 1.60% of the company’s stock.

HCA Healthcare Trading Up 0.7 %

Shares of HCA opened at $321.99 on Friday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The firm has a market cap of $79.96 billion, a price-to-earnings ratio of 14.66, a PEG ratio of 1.10 and a beta of 1.64. The business’s fifty day moving average is $316.15 and its 200-day moving average is $347.99.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the company posted $5.90 EPS. Equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.89%. The ex-dividend date of this dividend is Monday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is presently 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.